We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Stericycle (SRCL) Stock Rises 10% in 6 Months: Here's How
Read MoreHide Full Article
Stericycle, Inc. shares have had an impressive run in the past six months. The stock has gained 9.7% compared with the 9.9% rally of the Zacks S&P 500 composite.
Reasons for the Upside
The services that Stericycle provides usually cannot be delayed and are required on a scheduled basis, allowing the company to achieve a steady flow of revenues. It has strong customer relationships, most of which include long-term contracts ranging from three to five years. This enables it to maintain a revenue retention rate of around 90%.
Stericycle has progressed well with its key objectives of the program, including improving the quality of revenues; driving operational efficiency through work measurement, asset optimization, technology, strategic sourcing; portfolio rationalization through divestitures; debt reduction and leverage improvement; and ERP implementation.
The company is likely to benefit from ongoing trends such as increasing environmental concerns, rapid industrialization, increase in population and active government measures to reduce illegal dumping.
Zacks Rank and Stocks to Consider
Stericycle currently carries a Zacks Rank #3 (Hold).
Here are some better-ranked stocks from the broader Business Service sector, which you may consider.
Verisk Analytics (VRSK - Free Report) beat the Zacks Consensus Estimate in three of the four previous quarters and matched on one instance, with an average surprise of 9.9%. The consensus mark for 2023 revenues is pegged at $2.66 billion, which reflects a decrease of 8.2% from the year-ago figure. Earnings are pegged at $5.71 per share for 2023, which is 14% above the year-ago figure. VRSK currently has a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Automatic Data (ADP - Free Report) presently has a Zacks Rank of 2. The company beat the Zacks Consensus Estimate in all the trailing four quarters, the average surprise being 3.1%. The consensus estimate for fiscal 2024 revenues and earnings implies growth of 6.3% and 11.1% year over year, respectively.
Broadridge (BR - Free Report) currently carries a Zacks Rank of 2. It beat the Zacks Consensus Estimate in two of the trailing four quarters, missed once and matched on one instance, the average surprise being 0.5%. The consensus estimate for fiscal 2024 revenues and earnings indicates a rise of 7.2% and 8.8% year over year, respectively.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Stericycle (SRCL) Stock Rises 10% in 6 Months: Here's How
Stericycle, Inc. shares have had an impressive run in the past six months. The stock has gained 9.7% compared with the 9.9% rally of the Zacks S&P 500 composite.
Reasons for the Upside
The services that Stericycle provides usually cannot be delayed and are required on a scheduled basis, allowing the company to achieve a steady flow of revenues. It has strong customer relationships, most of which include long-term contracts ranging from three to five years. This enables it to maintain a revenue retention rate of around 90%.
Stericycle, Inc. Price and Consensus
Stericycle, Inc. price-consensus-chart | Stericycle, Inc. Quote
Stericycle has progressed well with its key objectives of the program, including improving the quality of revenues; driving operational efficiency through work measurement, asset optimization, technology, strategic sourcing; portfolio rationalization through divestitures; debt reduction and leverage improvement; and ERP implementation.
The company is likely to benefit from ongoing trends such as increasing environmental concerns, rapid industrialization, increase in population and active government measures to reduce illegal dumping.
Zacks Rank and Stocks to Consider
Stericycle currently carries a Zacks Rank #3 (Hold).
Here are some better-ranked stocks from the broader Business Service sector, which you may consider.
Verisk Analytics (VRSK - Free Report) beat the Zacks Consensus Estimate in three of the four previous quarters and matched on one instance, with an average surprise of 9.9%. The consensus mark for 2023 revenues is pegged at $2.66 billion, which reflects a decrease of 8.2% from the year-ago figure. Earnings are pegged at $5.71 per share for 2023, which is 14% above the year-ago figure. VRSK currently has a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Automatic Data (ADP - Free Report) presently has a Zacks Rank of 2. The company beat the Zacks Consensus Estimate in all the trailing four quarters, the average surprise being 3.1%. The consensus estimate for fiscal 2024 revenues and earnings implies growth of 6.3% and 11.1% year over year, respectively.
Broadridge (BR - Free Report) currently carries a Zacks Rank of 2. It beat the Zacks Consensus Estimate in two of the trailing four quarters, missed once and matched on one instance, the average surprise being 0.5%. The consensus estimate for fiscal 2024 revenues and earnings indicates a rise of 7.2% and 8.8% year over year, respectively.